Clinical Trials on Advanced Nonhematological Malignancies in United Kingdom
Total 3384 results
-
Millennium Pharmaceuticals, Inc.TerminatedAdvanced Nonhematological MalignanciesUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Nonhematologic MalignanciesUnited States, Spain, United Kingdom
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Nonhematologic MalignanciesUnited States, Spain, France, United Kingdom
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Nonhematologic MalignanciesUnited States
-
Millennium Pharmaceuticals, Inc.WithdrawnAdvanced Nonhematologic MalignanciesUnited States
-
Metronome TherapeuticsUnknownNonhematologic MalignanciesUnited States
-
Millennium Pharmaceuticals, Inc.CompletedCarcinoma, Basal Cell | Advanced Nonhematologic MalignanciesUnited States
-
AstraZenecaCompletedAdvanced Solid MalignanciesUnited Kingdom
-
PfizerCompletedAdvanced Non-Hematologic MalignanciesUnited Kingdom
-
AstraZenecaParexelCompletedAdvanced MalignanciesUnited Kingdom, United States
-
PfizerTerminatedAdvanced Non-Hematologic MalignanciesUnited States, United Kingdom
-
BioInvent International ABMerck Sharp & Dohme LLCRecruitingAdvanced MalignanciesUnited Kingdom, Denmark, Hungary, Russian Federation
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United KingdomUnknownAdvanced Solid MalignanciesUnited Kingdom
-
Boston PharmaceuticalsCompletedAdvanced Nonhaematologic MalignanciesUnited Kingdom
-
Janssen Research & Development, LLCRecruitingAdvanced Solid MalignanciesUnited States, Korea, Republic of, Canada, United Kingdom
-
Carrick Therapeutics LimitedCompletedAdvanced Solid MalignanciesUnited States, United Kingdom
-
Bristol-Myers SquibbCompletedAdvanced MalignanciesUnited States
-
Symphony Evolution, Inc.Completed
-
Novartis PharmaceuticalsCompletedAdvanced MalignanciesUnited States
-
Mirati Therapeutics Inc.CompletedAdvanced MalignanciesUnited States
-
Millennium Pharmaceuticals, Inc.CompletedLymphoma | Nonhematologic MalignanciesUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced MalignanciesUnited States
-
Heidelberg Pharma AGUnited States Department of DefenseCompletedAdvanced MalignanciesUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Gastrointestinal MalignanciesUnited States
-
Mayo ClinicGlaxoSmithKlineCompletedAdvanced Solid MalignanciesUnited States
-
Mirati Therapeutics Inc.CompletedAdvanced MalignanciesUnited States
-
Novartis PharmaceuticalsTerminatedAdvanced MalignanciesUnited States
-
MedImmune LLCCompletedAdvanced MalignanciesUnited States
-
Summa Health SystemTerminatedAdvanced Bulky MalignanciesUnited States
-
Zhuhai Yufan Biotechnologies Co., LtdRecruitingAdvanced Solid Tumor | Advanced Solid MalignanciesUnited States
-
Sumitomo Pharma America, Inc.CompletedCancer, Advanced MalignanciesCanada, United States
-
Infinity Pharmaceuticals, Inc.Terminated
-
Regeneron PharmaceuticalsWithdrawnAdvanced MalignanciesUnited States
-
Athenex, Inc.RecruitingAdvanced Solid MalignanciesUnited States
-
Novartis PharmaceuticalsCompletedA Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic FunctionAdvanced Malignancies | TumorsUnited States
-
Bristol-Myers SquibbTerminatedAdvanced Solid MalignanciesUnited States, Canada
-
AstraZenecaTerminatedCancer | Advanced Solid Tumors | Advanced Solid MalignanciesUnited States
-
Georgetown UniversityPfizerUnknownAdvanced Solid Tumor MalignanciesUnited States
-
AstraZenecaTerminatedCancer | Advanced Solid MalignanciesUnited States, Italy, United Kingdom, France, Germany, Spain, Netherlands
-
Regeneron PharmaceuticalsSanofiCompletedAdvanced Solid MalignanciesUnited States
-
Incyte CorporationTerminatedAdvanced MalignanciesUnited States, Italy, Denmark, Japan
-
New Mexico Cancer Care AllianceCompletedAdvanced Solid Tumor MalignanciesUnited States
-
Georgiamune IncRecruitingAdvanced Solid MalignanciesUnited States
-
Novartis PharmaceuticalsCompletedA Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic FunctionAdvanced Malignancies | TumorsUnited States
-
SCRI Development Innovations, LLCNovartisCompletedAdvanced Malignancies | Refractory MalignancyUnited States
-
Novartis PharmaceuticalsCompletedSolid Tumors | Advanced MalignanciesUnited States
-
Regeneron PharmaceuticalsTerminatedAdvanced PD-L1 Positive MalignanciesUnited States
-
Reata, a wholly owned subsidiary of BiogenCompletedAdvanced Solid Tumors | Lymphoid MalignanciesUnited States
-
Washington University School of MedicineCompletedSolid Tumors | Advanced Gastrointestinal MalignanciesUnited States
-
Athenex, Inc.CompletedAdvance MalignanciesUnited States